A polymorphism is a natural variation in DNA that occurs commonly in a population. To qualify as a polymorphism rather than a rare mutation, the variant must appear in at least 1% of the general population. These variations are the reason people differ in traits like eye color, height, ability to digest milk, and how they respond to medications. Most polymorphisms have no effect on health at all, but some influence disease risk or drug metabolism in meaningful ways.
How Polymorphisms Differ From Mutations
Traditionally, geneticists used “mutation” for rare, harmful DNA changes and “polymorphism” for common, harmless ones. That 1% population frequency was the dividing line. But this shorthand created confusion: some common variants do affect health, and some rare ones are perfectly harmless. To fix this, the American College of Medical Genetics now recommends using the neutral term “variant” for all DNA changes, paired with a clinical label: pathogenic, likely pathogenic, uncertain significance, likely benign, or benign.
You’ll still encounter “polymorphism” everywhere in genetics, lab reports, and health articles. It remains a useful word for describing normal genetic diversity. Just know that “common” doesn’t automatically mean “harmless,” and the field is shifting toward more precise language.
Types of Polymorphisms
The most studied type is the single nucleotide polymorphism, or SNP (pronounced “snip”). A SNP is a one-letter change in the DNA code. Your genome contains billions of these letters, and on average, two unrelated people differ at about one position in every 1,300. That adds up to millions of SNPs scattered across the genome, making them the most common form of genetic variation. Consumer DNA tests like 23andMe and AncestryDNA work primarily by reading hundreds of thousands of SNPs.
Other polymorphisms involve bigger structural changes. Copy number variations occur when a segment of DNA is duplicated or deleted, so different people carry different numbers of copies. These segments can be short or span thousands of DNA bases. Repeating sequences called short tandem repeats (STRs) are another category. In these, a short pattern of two to five letters repeats a variable number of times. STRs are highly variable between individuals, which makes them the foundation of forensic DNA profiling. When crime labs run a DNA sample through a national database, they’re comparing STR patterns at specific locations in the genome to look for a match.
Polymorphisms That Shape Everyday Biology
One well-known example is lactase persistence, the ability to digest milk sugar into adulthood. A single SNP near the gene for the lactase enzyme determines whether you keep producing it after childhood. The version that allows continued milk digestion is found in 70% to 80% of Northern Europeans but only 5% to 10% of Southern Europeans. In many East Asian and West African populations, the persistence variant is even rarer. This geographic pattern reflects thousands of years of natural selection in herding cultures where fresh milk was a reliable calorie source.
Polymorphisms also explain why the same medication can work perfectly in one person and cause serious side effects in another. A family of liver enzymes is responsible for breaking down a large share of prescription drugs. Genetic variants in these enzymes sort people into rough metabolic categories. “Poor metabolizers” carry two nonfunctional copies of an enzyme gene and break down certain drugs very slowly, allowing the drug to build up to toxic levels. “Ultra-rapid metabolizers” carry extra copies of the gene and chew through drugs so fast that either the medication doesn’t work or its breakdown products accumulate dangerously.
The consequences can be severe. People who metabolize the blood thinner warfarin slowly face a higher risk of bleeding events at standard doses. On the other end, ultra-rapid metabolizers who take codeine convert it into morphine so quickly that life-threatening respiratory depression has occurred, including a fatal case in a breastfed newborn whose mother was an ultra-rapid metabolizer taking codeine for pain. These examples are the reason pharmacogenomic testing, which reads your drug-relevant polymorphisms, is becoming more common before certain prescriptions.
When a “Common” Variant Isn’t a Health Risk
The MTHFR gene offers an important cautionary tale. In 1995, researchers identified a common SNP in this gene that reduces the activity of an enzyme involved in processing the B vitamin folate. A second reduced-activity variant was discovered shortly after. These polymorphisms are extremely common: 60% to 70% of the population carries at least one copy, and about 10% carry two copies or a combination of both variants.
For years, MTHFR variants were included in lab panels testing for inherited blood-clotting disorders, and they remain a source of anxiety for patients who discover them. But the evidence is now clear: these polymorphisms are not risk factors for blood clots. Multiple professional organizations, including the American College of Medical Genetics and the American College of Obstetricians and Gynecologists, have stated that MTHFR testing should not be part of clotting disorder workups. The variants are real, but their clinical significance for thrombosis is essentially zero. This is a good reminder that having a polymorphism in a gene with an important-sounding name does not mean you have a medical problem.
How Polymorphisms Are Detected
SNPs are typically identified through genotyping arrays, which are chips that can read hundreds of thousands of known variants from a single saliva or blood sample. This is the technology behind most consumer genetic tests and many clinical pharmacogenomic panels. Whole genome sequencing reads every letter of your DNA and can detect SNPs, insertions, deletions, and structural changes all at once, though it costs more and generates far more data to interpret.
STR analysis, the type used in forensic labs, works differently. Specific repeat regions are amplified and measured for length. Because these repeats vary so much between individuals, comparing patterns at multiple locations produces a DNA profile that is, for practical purposes, unique. National forensic databases store these STR profiles so that evidence from crime scenes can be checked against known samples for a match.
Why Polymorphisms Matter for You
If you’ve taken a consumer DNA test, had pharmacogenomic testing before a prescription, or received results from a genetic health screen, the results you’re reading are polymorphisms. Most are neutral passengers in your genome. Some influence visible traits or minor biological quirks. A smaller number affect how you process medications or modestly shift your risk for certain conditions. The key is context: a polymorphism only matters when there’s solid evidence linking it to a specific outcome, and many variants that sound alarming on a lab report, like MTHFR, turn out to have little or no clinical impact.